However, it is important to consider our study period and the recent launch of the 3.0 mg and 4.5 mg dosage formulations in France in July 2021, as well as the coronavirus disease (COVID-19) pandemic, which decreased access to primary care access and may have potentially lessened the likelihood of initiating new dosage formulations in patients [16, 17]
Second, considering the biological latency of GLP-1 RAs as well as the potential underdiagnosis of DR at baseline, we, therefore, undertook the analysis by excluding patients with less than 6 months of follow-up
How can I prevent retatrutide injection site reactions
It promotes lipolysis , the breakdown of triglycerides into free fatty acids used for energy, aiding in reductions in body fat percentage (Yaspelkis & Ivy, American Journal of Physiology )